Metraipolis › archive › dc_72afc360a2ce

Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland — Europe PMC PMID:40904494

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40904494
DOI
10.3389/fonc.2025.1617743
License (as archived)
solo-consultazione
Archived
2026-11-10T12:23:43.254Z
SHA-256 of the archived text
fc16e4100df5b5020ebb038825648ab35d36c60cb0477125da8a7c99cc13713c
Stable URL of this page
https://metraipolis.com/documento/dc_72afc360a2ce

How to cite

Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland — Europe PMC PMID:40904494 — Europe PMC (en), https://europepmc.org/article/MED/40904494 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72afc360a2ce (Metraipolis archive dc_72afc360a2ce, sha256 fc16e4100df5b5020ebb038825648ab35d36c60cb0477125da8a7c99cc13713c)
BibTeX
@misc{dc72afc360a2ce,
  title = {Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland — Europe PMC PMID:40904494},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40904494},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72afc360a2ce; sha256 fc16e4100df5b5020ebb038825648ab35d36c60cb0477125da8a7c99cc13713c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904494. Agents can read the archived copy with the MCP tool read_document.